Hosted on MSN1y
ResMed product recall classified as most serious by FDA (update)
The products can be used with BiPAP and CPAP machines from other manufacturers, and patients using those devices should ensure that their masks are not part of the recall. ResMed (RMD) said that ...
ResMed initiated with a Buy at Goldman Sachs
Goldman Sachs initiated coverage of ResMed (RMD) with a Buy rating and A$48.90 price target The firm says its Buy thesis is based on “robust” ...
Balanced Outlook on ResMed: Strong Execution and Innovations Offset by Valuation Concerns and Market Challenges
Adam Maeder, an analyst from Piper Sandler, has initiated a new Hold rating on Resmed (RMD).Stay Ahead of the Market:Discover outperforming ...